Hoff, P M <br/><br/>
Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy.  [electronic resource] 

 -  Cancer  May 2000 
 - 2054-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1097-0142(20000501)88:9<2054::aid-cncr11>3.0.co;2-j  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Hormonal--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Carcinoma--drug therapy<br/>Disease<br/>Disease-Free Survival<br/>Endometrial Neoplasms--chemically induced<br/>Estrogen Antagonists--adverse effects<br/>Feasibility Studies<br/>Female<br/>Follow-Up Studies<br/>Frail Elderly<br/>Humans<br/>Mastectomy, Segmental<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Recurrence, Local--pathology<br/>Neoplasm Staging<br/>Receptors, Estrogen--analysis<br/>Remission Induction<br/>Selective Estrogen Receptor Modulators--adverse effects<br/>Survival Rate<br/>Tamoxifen--adverse effects<br/>Treatment Outcome